Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | FiercePharma
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
After turbulent years, Teva CEO Schultz forecasts stability - The Jerusalem Post
Mexico's social security agency sues Israel's Teva for allegedly bribing doctors - Business - Haaretz.com
Teva CEO stands down during troubled times - MedCity News
Teva finally announces successful CEO appointment | Pharmafile
Teva CEO to Step Down, Be Replaced by Chairman | Fortune
Teva CEO Erez Vigodman Steps Down | CHEManager
Teva CEO reportedly wanted to stay in his job | The Times of Israel
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
Teva sees higher margins, lower debt from restructuring | Financial Times
Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters
Teva CEO tells PM no bending on mass redundancy plan
Teva Pharmaceutical CEO on Bringing His Company Back from the Brink | Barron's
Teva CEO on decimated share price: "It's rational enough from a market point of view"
Erez Vigodman steps down as Teva CEO
Shlomo Yanai, incoming president and CEO (L), and Israel Makov, outgoing president and CEO of Teva Pharmaceutical Industries, Ltd., take part in the opening bell ceremonies at the NASDAQ in New York
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva Pharmaceutical Industries names a new CEO
US Congress grills Teva CEO on Copaxone price hikes - Globes
U.S. accuses Israel's Teva of fixing drug prices
Teva snags new CEO from Lundbeck
Teva Pharma CEO: We see a stable U.S. market place for our generics - The Global Herald
Who's Kare Schultz, (NYSE:TEVA) New CEO In Charge Of Teva? | Benzinga
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
Shlomo Yanai, incoming president and CEO of Teva Pharmaceutical Industries, Ltd., takes part in the opening bell ceremonies at the NASDAQ in New York on February 21, 2007. (UPI Photo/Laura Cavanaugh Stock
